1. Home
  2. SPSC vs MLYS Comparison

SPSC vs MLYS Comparison

Compare SPSC & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPS Commerce Inc.

SPSC

SPS Commerce Inc.

HOLD

Current Price

$59.95

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$23.85

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPSC
MLYS
Founded
1987
2019
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2009
2023

Fundamental Metrics

Financial Performance
Metric
SPSC
MLYS
Price
$59.95
$23.85
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$100.89
$48.67
AVG Volume (30 Days)
753.5K
1.0M
Earning Date
04-23-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
20.59
37.43
EPS
2.46
N/A
Revenue
$220,566,000.00
N/A
Revenue This Year
$8.91
N/A
Revenue Next Year
$7.30
N/A
P/E Ratio
$24.37
N/A
Revenue Growth
14.11
N/A
52 Week Low
$52.56
$10.44
52 Week High
$153.16
$47.65

Technical Indicators

Market Signals
Indicator
SPSC
MLYS
Relative Strength Index (RSI) 38.41 29.67
Support Level $52.56 $13.42
Resistance Level $64.46 $31.09
Average True Range (ATR) 2.45 1.78
MACD 1.01 -0.23
Stochastic Oscillator 55.70 3.38

Price Performance

Historical Comparison
SPSC
MLYS

About SPSC SPS Commerce Inc.

SPS Commerce Inc is a provider of cloud-based supply chain management services for retailers, grocers, distributors, suppliers, and logistics firms to increase supply chain performance, optimize inventory levels and sell-through, reduce operational costs, improve order visibility, and satisfy consumer demands for a seamless omnichannel experience. Its solutions are delivered through the SPS Commerce platform and provide integrations and retail performance analytics to its customers. Its products are; Fulfillment, Analytics, and Other products like Assortment and Community also it provides one-time services such as professional services and testing and certification. The group derives revenue from subscription-based recurring revenue services.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: